The Wegovy maker’s once-daily pill to treat type 2 diabetes has shown it cuts the risk of heart attacks and strokes in patients by up to 14%, according to a new trial.

The Franco-Italian eyewear group’s revenue rose 4% in the third quarter, helped by sales of smart glasses.

Find insight on Mondi, BHP, International Paper and more in the latest Market Talks covering Basic Materials.

The fashion concern said its performance improved in both its retail and wholesale channels, with increased revenue across all its markets, in particular in the Americas.

The consulting firm is cutting back on state-linked clients and is working to separate its China operations

Omead Afshar, who used to work in the office of the CEO, has moved into a vice president role with sales and manufacturing operations under him.